⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Vermillion Health and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Vermillion Health
↗Auckland, New Zealand
Vermillion Health is a medical technology company focused on developing non-invasive, drug-free neurofeedback solutions for chronic pain management. Their flagship technology, Alevia, utilizes EEG-based neurofeedback to help patients retrain neural pathways associated with pain perception through home-based, adaptive training sessions.
The company leverages neuroplasticity and real-time data to provide personalized cognitive rehabilitation. By combining medical-grade EEG hardware with mobile applications, Vermillion Health aims to offer accessible, clinically informed alternatives to traditional pharmacological pain management.
CLASSIFICATION
Company Type:Digital Health
Therapeutic Areas:
Industry:Digital Health
Sub-Industry:Neurotechnology / Pain Management
SIZE & FINANCIALS
Employees:1-50
Ownership:private
Status:operating
PIPELINE
Stage:Commercial
Lead Drug Stage:Commercial (Alevia System)
Modalities:Neurofeedback, EEG, Digital Therapeutics
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Key Partnerships:Exsurgo Ltd (Technology/Rental agreement)
COMPETITION
Position:Niche Player
LEADERSHIP
Key Executives:
Richard (Co-founder) - Co-founder
Robert - Medical Device Engineer
LINKS
Website:vermillionhealth.com
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Vermillion Health. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.